Gretchen Murphy
Senior Director, Corporate and R&D Communications and Patient Advocacy
Alkermes
T2Bmeet
Q3 T2Bmeet @ Boston 2026
Thursday, September 17th
4:30-7 p.m. ET
900 Winter St, Waltham, MA 02451
Register for T2Bmeet @ Boston
T2B Pro or T2B Student members: get your promo code here
Look for an automated confirmation email and calendar invite within one business day from our event management platform, Luma. If you do not receive it, check your spam folder or contact us at [email protected].
New at the Q3 T2Bmeet @ Boston: Coaches Corner
Get focused support for a real workplace challenge in a 20-minute Power Coaching Session with leadership coaches Carly Goldsmith or Deb Becker. Both bring deep experience working with communications professionals and leaders in the biotech industry. Use your session to think through a decision, team dynamic, difficult conversation, or other pressing challenge and leave with greater clarity, confidence, and practical next steps. Sessions will be available during the event’s networking portions, with onsite sign-up when you arrive.
Panel Discussion: Staying Relevant Between Milestones
In biopharma, attention spikes around data readouts, regulatory decisions, financings, partnerships, and launches. We’re the ones responsible for keeping a company’s story alive in between, translating steady, unglamorous progress into something stakeholders can still follow. Yet staying visible between catalysts means walking a line: go too quiet and the narrative stalls, say too much and it starts to look manufactured. This panel opens a discussion on how communicators sustain narrative momentum between major catalysts, decide which interim stories are worth telling, and protect credibility for when it matters most.
Key Takeaways:
- Tie individual announcements to a bigger enterprise narrative that can evolve through pipeline setbacks, leadership changes, and shifting timelines, while keeping the company’s credibility intact.
- Sustain stakeholder confidence during long stretches when meaningful work is underway but headline results aren’t.
- Identify which scientific, corporate, patient, leadership, and organizational stories meaningfully advance positioning, and who the right voice is to carry them.
- Protect visibility without manufacturing news, overstating the data, or setting expectations the business can’t support.
Program:
- 4:30-5 p.m. – Check-in and networking
- 5-5:45 p.m. – Panel discussion and Q&A
- 5:45-7 p.m. – Reception and networking
Meet our speakers
About our host
Alkermes, Inc.
Alkermes applies its decades of deep neuroscience expertise to develop medicines designed to help people living with complex, chronic psychiatric and neurological disorders. A global biopharmaceutical company headquartered in Dublin, Ireland, with U.S. locations in Massachusetts and Ohio, we seek to make a meaningful difference in the way people manage their diseases. Our patient-inspired science, integrated research strategy, sophisticated development capabilities and specialized commercial infrastructure enable us to pursue the development and commercialization of important new medicines in areas which are often overlooked, including addiction, serious mental illness and sleep disorders. Visit www.alkermes.com to learn more.
About our event sponsor
Biosector 2
B2 is a healthcare communications agency at the intersection of science and society. Through a highly collaborative approach to client service and award-winning storytelling, B2 transforms complex science into culturally relevant, behaviorally informed ideas and programs that connect brands with the people and communities they need to reach. As part of Syneos Health Communications, B2 combines dedicated healthcare expertise with the scale, resources and capabilities of a global network.